Professor of Medicine, UCLA
Internal Medicine
Dr. Benjamin J. Ansell, MD
|
|
Give Review
Benjamin Ansell practices Internal Medicine. He went to medical school at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a one of the best medicals schools. David Geffen School of Medicine at UCLA is ranked 13 in research and 7 in primary care medicine He received 23 awards: "Top Doctors:LA Area", "US News Best Doctors in America", "Patients Choice Compassionate Doctor", "Top Doctors:Southern California", "Best Doctors in America", "Compassionate Doctor", "Fellow, National Lipid Association", "Fellow", "Fellow, American College of Cardiology", "Best of Scientific Sessions 2003 American Heart Association", "Best of Scientific Sessions 2003", "Fellow, American College of Physicians", "Town and Country Best Physicians in America", "Town & Country Magazine: Top Doctors", "Best Physicians in America", "Merck Book Award, UCLA School of Medicine", "Merck Book Award", "Distinction in All Subjects", "Distinction in All Subjects, Cornell, University", "College Scholar, Cornell University", "College Scholar", "Super Doctor" and "Fellow (FACC)". Benjamin J. Ansell is also a published doctor. He has 33 publication published. The most recent publication is: A review of trials evaluating nonstatin lipid-lowering therapies. He is registered with Medicare and accepts Medicare payments.
Publications
- High-density lipoprotein as a therapeutic target: a systematic review.
- Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey.
- Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study.
- High-density lipoprotein function recent advances.
- hsCRP and HDL effects of statins trial (CHEST): rapid effect of statin therapy on C-reactive protein and high-density lipoprotein levels A clinical investigation.
- Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels...
- An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.
- The two faces of the 'good' cholesterol.
- A review of trials evaluating nonstatin lipid-lowering therapies.
- Not getting to goal: the clinical costs of noncompliance.
- Targeting the anti-inflammatory effects of high-density lipoprotein.
- HDL function as a target of lipid-modifying therapy.
- Modifying the anti-inflammatory effects of high-density lipoprotein.
- High-density lipoprotein: is it always atheroprotective?
- Evidence for a combined approach to the management of hypertension and dyslipidemia.
- Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under t...
- Rationale for combination therapy with statin drugs in the treatment of dyslipidemia.
- Anti-inflammatory properties of HDL.
- The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.
- Improvement in current approaches to lipid lowering.
- Future directions in lipid therapies.
- Cholesterol, stroke risk, and stroke prevention.
- Reassessment of National Cholesterol Education Program Adult Treatment Panel-III guidelines: one year later.
- The double jeopardy of HDL.
- Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus...
- Hyperlipidaemia and cardiovascular disease.
- The paradox of dysfunctional high-density lipoprotein.
- Mechanisms of disease: proatherogenic HDL--an evolving field.
- Appropriate first-line lipid-lowering therapy for type 1 diabetes mellitus.
- Developing a clinical strategy for cholesterol management in an era of unanswered questions.
- Managing borderline levels of risk for coronary heart disease: two illustrative case presentations.
- The potential for CETP inhibition to reduce cardiovascular disease risk.
Schools
David Geffen School Of Medicine At UCLA University Of California Los Angeles
UCLA Med Center
Cornell University
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- Top Doctors:LA Area
- US News Best Doctors in America
- Patients’ Choice “Compassionate Doctorâ€Â
- Top Doctors:Southern California
- Best Doctors in America
- Compassionate Doctor
- Fellow, National Lipid Association
- Fellow
- Fellow, American College of Cardiology
- “Best of Scientific Sessions 2003†American Heart Association
- “Best of Scientific Sessions 2003â€Â
- Fellow, American College of Physicians
- Town and Country “Best Physicians in Americaâ€Â
- Town & Country Magazine: Top Doctors
- “Best Physicians in Americaâ€Â
- Merck Book Award, UCLA School of Medicine
- Merck Book Award
- Distinction in All Subjects
- Distinction in All Subjects, Cornell, University
- College Scholar, Cornell University
- College Scholar
- Super Doctor
- Fellow (FACC)
Education
-
UCLA Medical Center -
David Geffen School of Medicine at UCLA -
Cornell University
Hospital
-
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1770516882 | |
| NPPES Provider LastName | ANSELL | |
| NPPES Provider FirstName | BENJAMIN | |
| NPPES Provider ZIPCode | 900953075 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 888.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1770516882 |
| Last Name Of The Provider | ANSELL |
| First Name Of The Provider | BENJAMIN |
| View All |
Similar Doctors
|
|
Dr. Martin A. Quan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan M. Helali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda G. Sterry, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nemish S. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth O. Beale, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel R. Wosk, MD |
|
|
Dr. Miriam C. Padilla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joy S. Feld, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Babak Yasmeh, MD
This Doctor is OpenDoctor Recommended.
|